| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515140 Psychological disorders; sleep disorders; anticonvulsants; cognition activators; drug abruse |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515131 Imaging mammal brain tissue via administering technetium, piperidine derivative complex |
| 02/04/2003 | US6515130 The invention relates to a process of preparing (S-(R*,S*))-beta -(((1-(1-oxo-3-(4-piperidinyl)propyl)-3-piperidinyl) carbonyl)amino)-3-pyridinepropanoic acid derivatives represented by the antagonists of the platelet fibrinogen |
| 02/04/2003 | US6515128 Dissolving 6-hydroxy-3,4-dihydroquinolinone and a base in water; dissolving a 1-cyclohexyl-5- (4-halobutyl)-tetrazole in water-immiscible solvent, mixing aqueous phase and organic phase in presence of phase transfer catalyst; recovering |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515013 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6514998 For controlling animal pests and harmful fungi |
| 02/04/2003 | US6514997 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/04/2003 | US6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514977 For treating p38 kinase mediated disorders |
| 02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/04/2003 | US6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity |
| 02/04/2003 | US6514971 Cinnoline derivatives and use as medicine |
| 02/04/2003 | US6514970 Urotensin-II receptor antagonists |
| 02/04/2003 | US6514968 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising |
| 02/04/2003 | US6514966 Compounds for the treatment of obesity |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 01/30/2003 | WO2003008559A2 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 01/30/2003 | WO2003008515A1 Tertiary diamines containing heterocyclic groups and their use in organic electroluminescent devices |
| 01/30/2003 | WO2003008409A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/30/2003 | WO2003008408A1 Polymorph of the antihistamine norastemizole |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003008406A1 Improved process for preparing benzimidazole-type compounds |
| 01/30/2003 | WO2003008405A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 01/30/2003 | WO2003008398A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | WO2003008392A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 01/30/2003 | WO2003008387A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 01/30/2003 | WO2003007964A1 Remedial or preventive agent for cardiopathy or aneurysm containing chymase inhibitory compound |
| 01/30/2003 | WO2003007959A1 Quinoxaline derivatives which have parp inhibitory action |
| 01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007949A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 01/30/2003 | WO2003007945A1 Viral polymerase inhibitors |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2003007883A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 01/30/2003 | WO2002053097A3 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 01/30/2003 | WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors |
| 01/30/2003 | US20030023100 For therapy of inflammatory and allergic reactions, drug or alcohol abuse, diarrhoea, gastritis, ulcers, cardiovascular diseases, urinary incontinence, depressions, states of shock, migranes, narcolepsy, overweight, asthma, glaucoma, etc. |
| 01/30/2003 | US20030023098 Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
| 01/30/2003 | US20030023094 Process for the preparation of (pyridinylidene)-phthalides |
| 01/30/2003 | US20030023093 For use as antitumor agents |
| 01/30/2003 | US20030023091 For therapy and prophylaxis of peptic ulcers, gastro intestinal inflammatory diseases like duodenal/ gastric ulcer or gastritis or other gastro intestinal disorders |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/30/2003 | US20030022929 Method of using soluble epoxide hydrolase inhibitors |
| 01/30/2003 | US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors |
| 01/30/2003 | US20030022903 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/30/2003 | US20030022902 Based upon 2-(N-(7-benzyl-9-methyl-1,5-dioxonan-2,6-dione-3-yl)amido)-3-hydroxy-4 -methoxypyridine; use as agricultural fungicide |
| 01/30/2003 | US20030022900 Compositions comprising alpha-1C specific compounds |
| 01/30/2003 | US20030022899 S-6-hydroxy-buspirone |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/30/2003 | US20030022887 Unsymmetrical cyclic diamine compound |
| 01/30/2003 | US20030022886 Bis (2-aryl-5-pyridyl) derivatives |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | US20030022884 Heterocycle derivatives and drugs |
| 01/30/2003 | US20030022794 Bioactive pesticides |
| 01/30/2003 | US20030020603 Vehicular sound-processing system incorporating an interior mirror user-interaction site for a restricted-range wireless communication system |
| 01/30/2003 | US20030019050 Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing |
| 01/30/2003 | CA2454187A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 01/30/2003 | CA2454007A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | CA2453633A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | CA2453594A1 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 01/30/2003 | CA2450437A1 1-phenylsulphonyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application |
| 01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/29/2003 | EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 01/29/2003 | EP1278743A1 Novel anti-infectives |
| 01/29/2003 | EP1278741A1 Muscarinic agonists |
| 01/29/2003 | EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 01/29/2003 | EP1278735A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 01/29/2003 | EP1278733A1 Process for the preparation of sterically hindered aryloxyamines |
| 01/29/2003 | EP1278732A1 1-aroyl-piperidinyl benzamidines |
| 01/29/2003 | EP1278728A1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 01/29/2003 | EP1278520A1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 01/29/2003 | EP1278502A2 Protease inhibitors |
| 01/29/2003 | EP1105387B1 Prodrugs of proton pump inhibitors |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP1028948B1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 01/29/2003 | EP0910573B1 New amino acid derivatives and their use as thrombin inhibitors |
| 01/29/2003 | EP0854865B1 Combinatorial solid phase synthesis of a library of indole derivatives |
| 01/29/2003 | EP0846113B1 1-(pyridyl)-pyrazols and their use as herbicides |
| 01/29/2003 | EP0817772B1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/29/2003 | EP0708769B1 Substituted 2-fused phenylpyridines with herbicidal activity |
| 01/29/2003 | CN1394205A Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1394202A Picolinic acid derivatives and their use as fungicides |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/29/2003 | CN1100054C Process for making HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butyl carboxamide |
| 01/29/2003 | CN1100053C Quinolone carboxylic acid derivatives or salts thereof |
| 01/29/2003 | CN1100046C 喹唑啉衍生物 Quinazoline derivatives |